Veerhealth Care Ltd (NIYATILEAS) — Board Meeting | 31 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
34th AGM scheduled for September 23, 2026, with director reappointments and e-voting process
🔮 What's Next
No explicit future guidance provided
💡 Investor Takeaway
The company shows strong revenue and profit growth with no dividend, but promoter concentration remains high at 31.50% for shareholders to monitor

The 34th AGM of Veerhealth Care Limited (BSE: NIYATILEAS) scheduled for September 23, 2026, will focus on director reappointments, auditor confirmation, and shareholder voting via NSDL e-Voting. The company reported a 95% revenue jump to [amount not verified] and 39% PAT growth to ₹54.40 lakhs for FY 2025-26, with no dividend recommended. Promoter holding stands at 31.50% amid stable governance and unmodified audit opinion.

📄 View Original Announcement (PDF)

About Veerhealth Care Ltd (NIYATILEAS)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹98.65 Cr P/E: 64.9 ROE: 6.9% ROCE: 11.2%

View full NIYATILEAS stock details →

📡 Get AI alerts when NIYATILEAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NIYATILEAS — Free

📊 More NIYATILEAS filings

See all NIYATILEAS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NIYATILEAS files new disclosures

Track NIYATILEAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NIYATILEAS — Free

Free account · 2 AI queries/day